Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Diagnostics › Immunoassays › Food Allergy Dx Firm AllerGenis, Luminex Ink Test Development Deal

Food Allergy Dx Firm AllerGenis, Luminex Ink Test Development Deal

Jan 16, 2019
|
staff reporter

NEW YORK (360Dx) – Food allergy diagnostic developer AllerGenis today announced a non-exclusive deal with Luminex for use of that company's xMAP technology to develop, market, and sell a precision food allergy diagnostic assay.

Financial and other terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Immunoassays

  1. NIH Funds $33M in COVID-19 Testing Projects for Safe Return of Students, Staff to School

  2. NIH Awards Qorvo Biotechnologies $24.4M for Rapid SARS-CoV-2 Antigen Test

  3. With Luminex Acquisition, DiaSorin to Broaden MDx Portfolio, Expand US Presence

    Premium

  4. Siemens Healthineers Gets CE Mark for Point-of-Care High-Sensitivity Cardiac Troponin I Test

  5. Snibe Diagnostic Obtains CE Mark for HIV Chemiluminescence Immunoassay

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.